Neuraxis (NRXS) Raw Materials (2024 - 2026)
Neuraxis (NRXS) posted Raw Materials of $28048.0 for Q1 2026, down 18.76% sequentially from $34524.0 in Q4 2025, and up 529.73% YoY from $4454.0 in Q1 2025.
Neuraxis (NRXS) Raw Materials (2024 - 2026) Analysis & Trends
Neuraxis has reported Raw Materials for 3 years, with the latest figure at $28048.0 in Q1 2026.
- Quarterly Raw Materials rose 529.73% year-over-year to $28048.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $28048.0 (up 529.73% YoY) and the FY2025 annual result came in at $34524.0, up 675.12% from the prior year.
- Raw Materials slipped to $28048.0 in Q1 2026 per NRXS's latest filing, from $34524.0 in the prior quarter.
- Over five years, Raw Materials peaked at $34524.0 in Q4 2025 and troughed at $4454.0 in Q4 2024.
- A 3-year average of $19578.0 and a median of $22621.5 in 2025 frame the typical range for Raw Materials.
- The sharpest annual moves came in 2025 and 2026: Raw Materials soared 675.12% in 2025, then surged 529.73% in 2026.
- Over 3 years, Raw Materials stood at $4454.0 in 2024, then jumped by 675.12% to $34524.0 in 2025, then dropped by 18.76% to $28048.0 in 2026.
- According to Business Quant data, Raw Materials over the past three periods registered $28048.0, $34524.0, and $28793.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Neuraxis | 74.54 Mn | 66.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10,926.00 |
| Mar 31, 2026 | 28,048.00 |
| Dec 31, 2025 | 34,524.00 |
| Sep 30, 2025 | 28,793.00 |
| Jun 30, 2025 | 17,195.00 |
| Mar 31, 2025 | 4,454.00 |
| Dec 31, 2024 | 4,454.00 |